Zobrazeno 1 - 10
of 758
pro vyhledávání: '"Patrizio Lancellotti"'
Autor:
Hector I. Michelena, Alessandro della Corte, Arturo Evangelista, Joseph J. Maleszewski, William D. Edwards, Mary J. Roman, Richard B. Devereux, Borja Fernández, Federico M. Asch, Alex J. Barker, Lilia M. Sierra-Galán, Laurent de Kerchove, Susan M. Fernandes, Paul W.M. Fedak, Evaldas Girdauskas, Victoria Delgado, Suhny Abbara, Emmanuel Lansac, Siddharth K. Prakash, Malenka M. Bissell, Bogdan A. Popescu, Michael D. Hope, Marta Sitges, Vinod H. Thourani, Phillippe Pibarot, Krishnaswamy Chandrasekaran, Patrizio Lancellotti, Michael A. Borger, John K. Forrest, John Webb, Dianna M. Milewicz, Raj Makkar, Martin B. Leon, Stephen P. Sanders, Michael Markl, Victor A. Ferrari, William C. Roberts, Jae-Kwan Song, Philipp Blanke, Charles S. White, Samuel Siu, Lars G. Svensson, Alan C. Braverman, Joseph Bavaria, Thoralf M. Sundt, Gebrine El Khoury, Ruggero de Paulis, Maurice Enriquez-Sarano, Jeroen J. Bax, Catherine M. Otto, Hans-Joachim Schäfers
Publikováno v:
Archivos de Cardiología de México, Vol 94, Iss 2 (2024)
Este consenso de nomenclatura y clasificación para la válvula aórtica bicúspide congénita y su aortopatía está basado en la evidencia y destinado a ser utilizado universalmente por médicos (tanto pediatras como de adultos), médicos ecocardio
Externí odkaz:
https://doaj.org/article/125e7431c8484ba5a45f217644ca1d1c
Autor:
Bart Meuris, Serdar Günaydın, Patrizio Lancellotti, Luigi Badano, Gabriel Aldea, Rita Herrenknecht, Elisa Cerutti, Sara Gaggianesi, Silvia Dipinto, Paola Morando, Jörg Kempfert
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 18, Iss 1, Pp 1-9 (2023)
Abstract Background Clinical evidence is commonly obtained through individual trials that are time-, cost- and resource-consuming, and which often leave unanswered clinically relevant questions. Umbrella studies have been developed to address the nee
Externí odkaz:
https://doaj.org/article/aff5cf937dd94a9eae6d47ce1cb90d1d
Autor:
Bram Roosens, Bernard Cosyns, Patrizio Lancellotti, Cécile Laroche, Christine Selton-Suty, Agnès Pasquet, Johan De Sutter, Philippe Unger, Bernard Paelinck, Paul Vermeersch, Andreea Motoc, Xavier Galloo, Bernard Iung, Gilbert Habib, on behalf of the EURO-ENDO Investigators Group
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 5, p 1371 (2024)
(1) Background: infective endocarditis (IE) is a significant health concern associated with important morbidity and mortality. Only limited, often monocentric, retrospective data on IE in Belgium are available. This prospective study sought to assess
Externí odkaz:
https://doaj.org/article/c179a829469d49c1937fda77d6df0067
Autor:
Tommaso Viva, Adriana Postolache, Mai-Linh Nguyen Trung, Pauline Danthine, Hélène Petitjean, Vito Domenico Bruno, Christophe Martinez, Mathieu Lempereur, Marco Guazzi, Samy Aghezzaf, Augustin Coisne, Cécile Oury, Raluca Dulgheru, Patrizio Lancellotti
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionAlthough staging of the extent of aortic stenosis (AS)-related cardiac damages is usually performed via echocardiography, this technique has considerable limitations in assessing pulmonary artery and right chamber pressures. The present h
Externí odkaz:
https://doaj.org/article/eb45766e7e294b4d99a126478216f8a2
Autor:
François Damas, Mai-Linh Nguyen Trung, Adriana Postolache, Hélène Petitjean, Mathieu Lempereur, Tommaso Viva, Cécile Oury, Raluca Dulgheru, Patrizio Lancellotti
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 2, p 409 (2024)
Recently, a staging system using 4 grades has been proposed to quantify the extent of cardiac damage associated with aortic stenosis (AS), namely AS-related cardiac damage staging (ASCDS). ASCDS is independently associated with all-cause mortality an
Externí odkaz:
https://doaj.org/article/e20723a8f9774d0e96f5aedf6725b652
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 21, p 6708 (2023)
Breast cancer is the leading cause of cancer death in women worldwide. Trastuzumab, the main HER2-targeted treatment, faces limitations due to potential cardiotoxicity. The management of patients with mild cardiotoxicity on trastuzumab remains uncert
Externí odkaz:
https://doaj.org/article/8e651c4c5b074658a9ea7ec8c05e30a0
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 17, p 5645 (2023)
It has been more than 20 years since the first in man transcatheter aortic valve intervention (TAVI), and during this period we have witnessed an impressive evolution of this technique, with an extension of its use from non-operable patients to high-
Externí odkaz:
https://doaj.org/article/76736635f1b84ef4818375e556e7dda3
Publikováno v:
Türk Kardiyoloji Derneği Arşivi, Vol 49, Iss 5, Pp 414-418 (2021)
Externí odkaz:
https://doaj.org/article/d91f913351bc43129055593f2bad3e45
Autor:
Anna Sannino, Federica Ilardi, Rebecca T. Hahn, Patrizio Lancellotti, Philipp Lurz, Robert L. Smith, Giovanni Esposito, Paul A. Grayburn
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundMedically managed tricuspid regurgitation (TR) has detrimental outcomes. Transcatheter tricuspid valve interventions (TTVIs) represent an alternative to surgery in high-risk patients; however, only early experiences exist.AimThe aim of this
Externí odkaz:
https://doaj.org/article/78afed039aa44f038a1d6ebf7ac0f4c3
Autor:
Vincent Tchana-Sato, Arnaud Ancion, Julien Tridetti, Natzi Sakalihasan, Marie Pierre Hayette, Olivier Detry, Philippe Delvenne, Philippe Amabili, Marc Senard, Olivier Hougrand, Delphine Szecel, Jean-Paul Lavigne, Elie Minga Lowampa, Charlotte Ponte, Isabelle Maquoi, Philippe Morimont, Melissa Van Den Bulck, Marie Helene Delbouille, Jean Olivier Defraigne, Patrizio Lancellotti
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background There are limited data on Coronavirus disease 2019 (COVID-19) in solid organ transplant patients, especially in heart transplant recipients, with only a few case reports and case series described so far. Heart transplant recipient
Externí odkaz:
https://doaj.org/article/d0ed0e8abf4a4f229c57b4c50a86b4be